Free release
1-(2-Fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one

1-(2-Fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one

CAS No. :1238697-26-1MDL No. :MFCD28385852Formula :C23H17FN6O2Boiling Point :-Linear Structure Formula :-InChI Key :KVHR

Sales:Service@apichina.com
CAS No. :1238697-26-1 Brand :Qitai
Formula :C23H17FN6O2 M.W :428.42

Introduction

CAS No. :1238697-26-1 MDL No. :MFCD28385852
Formula : C23H17FN6O2 Boiling Point : -
Linear Structure Formula :- InChI Key :KVHRYLNQDWXAGI-UHFFFAOYSA-N
M.W : 428.42 Pubchem ID :46848915
Synonyms :
TAK-063
Chemical Name :1-(2-Fluoro-4-(1H-pyrazol-1-yl)phenyl)-5-methoxy-3-(1-phenyl-1H-pyrazol-5-yl)pyridazin-4(1H)-one

Physicochemical Properties

Num. heavy atoms : 32
Num. arom. heavy atoms : 28
Fraction Csp3 : 0.04
Num. rotatable bonds : 5
Num. H-bond acceptors : 6.0
Num. H-bond donors : 0.0
Molar Refractivity : 115.96
TPSA : 79.76 Ų

Pharmacokinetics

GI absorption : High
BBB permeant : No
P-gp substrate : No
CYP1A2 inhibitor : No
CYP2C19 inhibitor : No
CYP2C9 inhibitor : Yes
CYP2D6 inhibitor : No
CYP3A4 inhibitor : Yes
Log Kp (skin permeation) : -6.24 cm/s

Lipophilicity

Log Po/w (iLOGP) : 3.22
Log Po/w (XLOGP3) : 3.77
Log Po/w (WLOGP) : 3.84
Log Po/w (MLOGP) : 2.39
Log Po/w (SILICOS-IT) : 2.38
Consensus Log Po/w : 3.12

Druglikeness

Lipinski : 0.0
Ghose : None
Veber : 0.0
Egan : 0.0
Muegge : 0.0
Bioavailability Score : 0.55

Water Solubility

Log S (ESOL) : -5.19
Solubility : 0.00277 mg/ml ; 0.00000647 mol/l
Class : Moderately soluble
Log S (Ali) : -5.14
Solubility : 0.00312 mg/ml ; 0.00000727 mol/l
Class : Moderately soluble
Log S (SILICOS-IT) : -7.13
Solubility : 0.0000317 mg/ml ; 0.000000074 mol/l
Class : Poorly soluble

Medicinal Chemistry

PAINS : 0.0 alert
Brenk : 0.0 alert
Leadlikeness : 2.0
Synthetic accessibility : 3.44
Signal Word:Warning Class:N/A
Precautionary Statements:P261-P305+P351+P338 UN#:N/A
Hazard Statements:H302-H315-H319-H335 Packing Group:N/A
GHS Pictogram: